A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

“There had been a perception that CNS, long known to be one of the most challenging areas of drug development, has been ...

For the first time, chemists have managed to create a type of molecule that was previously thought to be too unstable to ...

Much to the chagrin of investors looking to get rich quickly with a biopharma investment, the drug development cycle is, by ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an ...

The pharmaceutical industry has long been reliant on rigorous research and development processes to bring life-saving drugs to market. However, the traditional methods of drug development are ...

Toagosei Co (JP:4045) has released an update. Toagosei Co., Ltd. has invested 500 million yen in PeptiStar Inc., a company specializing in peptide ...

Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. While some ...

Experts have theorized that artificial intelligence will fundamentally alter the pharmaceutical sector by increasing the efficiency of drug development and lowering costs. And while its potential is ...

Misfolded proteins cause diseases like cystic fibrosis and ALS, making them prime candidates for quantum simulations in drug development. Classical computers struggle with the complexity of ...

Medical equipment maker Mettler-Toledo International beat third-quarter profit estimates on Thursday, helped by increased demand for its laboratory instruments used in drug development and research.